PureTech Health

PureTech Health Interest Expense

The Interest Expense of PureTech Health (PRTC.L) as of Nov 13, 2026 is 23.07 M USD. In the previous year, Interest Expense was 56.76 M USD — a change of -59.36% (lower).

Interest Expense

23.07 MUSD

YoY

-59.36%

Last updated:

Interest Expense of PureTech Health is 2024 23.07 M USD. Interest Expense of PureTech Health was 2023 56.76 M USD. It decreases by -59.36% lower compared to the previous year.

The PureTech Health Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2017
44.71 M USD
Jan 1, 2018
21.25 M USD
Jan 1, 2019
245.78 M USD
Jan 1, 2020
141.70 M USD
Jan 1, 2021
81.55 M USD
Jan 1, 2022
-80.51 M USD
Jan 1, 2023
56.76 M USD
Jan 1, 2024
23.07 M USD
The PureTech Health Interest Expense history
YEARInterest ExpenseYoY
23.07 MUSD-59.36%
56.76 MUSD-170.50%
-80.51 MUSD-198.73%
81.55 MUSD-42.45%
141.70 MUSD-42.35%
245.78 MUSD+1,056.61%
21.25 MUSD-52.47%
44.71 MUSD-815.36%
-6.25 MUSD+60.26%
-3.90 MUSD-71.82%
-13.84 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PureTech Health Stock analysis

What does PureTech Health do? PureTech Health is an innovative company specializing in the development of novel medical therapies and solutions. The company was founded in 2002 by Daphne Zohar and is headquartered in Boston, USA. PureTech Health is listed on the London Stock Exchange and has become one of the leading biotech companies in recent years. The company's business model is based on identifying medical needs and developing new products and therapies to meet those needs. It utilizes cutting-edge technologies to work quickly and effectively. Research and development are closely linked in an iterative process. PureTech Health's main focus is oncology, specifically developing immune-oncology therapies that target the patient's immune system to strengthen their body's defense against cancer cells. The company has also developed an innovative drug discovery system that combines nanotechnology and artificial intelligence. Another focus area for PureTech Health is gastroenterology. The company has developed a novel technology that selectively releases medical substances in the intestine, allowing targeted treatment of gastrointestinal diseases. PureTech Health has also developed a new method for diagnosing colorectal cancer based on the identification of bacteria in feces. In the field of neuropsychiatric disorders, the company has promising research results. It has developed a new technology that enables targeted manipulation of the central nervous system, allowing for the treatment of conditions such as depression, anxiety disorders, and ADHD. To this end, PureTech Health has developed a novel nasal spray that delivers the active ingredients directly to the brain. Biosensing is another area of focus for PureTech Health. The company has developed a novel technology that allows for the measurement of medical parameters such as blood sugar, cholesterol, and blood pressure. The sensors are available in the form of patches or other wearable devices and are easy and convenient to use. This technology is intended to help older people and those with chronic illnesses better monitor their health. Overall, PureTech Health is an innovative biotech company that is constantly seeking novel medical solutions. It operates in various areas and has promising products and therapies in the pipeline. With its close integration of research and development, PureTech Health is able to quickly and flexibly respond to market changes. With strong management and an experienced team, the company is well-positioned for further growth in the coming years. PureTech Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PureTech Health stock

Interest Expense of PureTech Health is 23.07 M USD in 2024.

Interest Expense of PureTech Health changed from 56.76 M USD to 23.07 M USD, representing a -59.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense PureTech Health since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's PureTech Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — PureTech Health

All Key Metrics — PureTech Health